HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Electronic Letters to:

Medicines information: Allison Donnelly and Carol Paton Safety of selective serotonin reuptake inhibitors in pregnancy Psychiatr Bull 2007; 31: 183-186 [Abstract] [Full text] [PDF]

eLetters: Submit a response to this article

Electronic letters published:

NICE have published antenatal and postnatal mental health guideline

Rachel Burbeck, Steve Pilling   (16 May 2007)

NICE have published antenatal and postnatal mental health guideline 16 May 2007
Rachel Burbeck, Systematic Reviewer National Collaborating Centre for Mental Health, Steve Pilling Send letter to journal: Re: NICE have published antenatal and postnatal mental health guideline rachel.burbeck{at}ucl.ac.uk Rachel Burbeck, et al.	In response to Donnelly and Paton's article on the current state of knowledge on the safety of antidepressants during pregnancy, we would like to point out that earlier this year NICE published a guideline on antenatal and postnatal mental health, which deals with the issues raised. For example, the guideline recommends that where treatment with paroxetine is normally recommended (such as in the treatment of depression, GAD or OCD) a safer drug be considered instead. It also covers the safety of other psychotropic medication, including tricyclic antidepressants, valproate, lithium, and antipsychotics, and makes specific recommendations regarding discussing treatment plans with women who are planning a pregnancy, or already pregnant or breastfeeding. See www.nice.org.uk/CG45 for more information.